Advances in gut science understanding feline IBD in 2026 are opening new pathways to more effective and welfare-positive treatment approaches.
Gut science advances in 2026 are creating new tools for feline IBD management that are both more effective and less invasive than traditional approaches. Microbiome-based diagnosis enables more targeted treatment. Biomarker panels reduce the need for repeated biopsies. FMT offers potential restoration of healthy microbiome without long-term medication burden. These advances represent genuine welfare improvements as more precise, effective treatment replaces less specific approaches.